Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Chemokine CXCR3 antagonists designed by Millennium and Kyowa Hakko

Nov. 27, 2002

Canadian approval for Thymoglobulin in renal transplant patients

Nov. 27, 2002

Japan Energy and Sumitomo describe new immunomodulators for cancer and other disorders

Nov. 26, 2002

Cannabinoid CB2 receptor modulators under study at Shionogi

Nov. 22, 2002

Cytos and Medarex collaborate for new drug targets in immunological diseases

Nov. 18, 2002

Myfortic receives first major approval in Switzerland

Nov. 8, 2002

Novel triptolide prodrugs and their use in cancer and autoimmune diseases

Nov. 8, 2002

LF-15-0195 induces long-term heart allograft survival in rat model

Nov. 4, 2002

Organ Recovery Systems cleared to market improved kidney perfusion solution

Nov. 4, 2002

Cell Therapeutics presents new inhibitors of IL-12 and IL-4 signaling for asthma, diabetes, etc.

Oct. 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....